Guangbo Y. Zhang

188 Shizi Road
Suzhou, 215006, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications

Azimuthally polarized vortex vector optical field enhances the lateral resolution of two-photon fluorescence microscopy imaging.

Azimuthally polarized vortex vector optical field enhances the lateral resolution of two-photon fluorescence microscopy imaging.

Journal: Optics letters
Published: February 27, 2026

EOAI3402143 inhibits lung adenocarcinoma progression through the NF-κB/NR4A1 pathway.

EOAI3402143 inhibits lung adenocarcinoma progression through the NF-κB/NR4A1 pathway.

Journal: Acta biochimica et biophysica Sinica
Published: October 11, 2025

HKI-357 inhibits castration-resistant prostate cancer by targeting UBE2C via the AKT signaling pathway.

HKI-357 inhibits castration-resistant prostate cancer by targeting UBE2C via the AKT signaling pathway.

Journal: Biochemical pharmacology
Published: June 15, 2025

TRIM32 promotes anoikis resistance and metastasis in NSCLC by degrading CHEK2 to enhance IL-6 secretion.

TRIM32 promotes anoikis resistance and metastasis in NSCLC by degrading CHEK2 to enhance IL-6 secretion.

Journal: Cell death and differentiation
Published: January 27, 2025

FASN promotes lipid metabolism and progression in colorectal cancer via the SP1/PLA2G4B axis.

FASN promotes lipid metabolism and progression in colorectal cancer via the SP1/PLA2G4B axis.

Journal: Cell death discovery
Published: November 09, 2024

FOLR2+ macrophage depletion from intestinal metaplasia to early gastric cancer: single-cell sequencing insight into gastric cancer progression.

FOLR2+ macrophage depletion from intestinal metaplasia to early gastric cancer: single-cell sequencing insight into gastric cancer progression.

Journal: Journal of experimental & clinical cancer research : CR
Published: October 23, 2024

Discovery of a novel BCL-2 inhibitor GW806742X for the treatment of TNBC.

Discovery of a novel BCL-2 inhibitor GW806742X for the treatment of TNBC.

Journal: Biochemical pharmacology
Published: October 16, 2024

Elevated SPARC Disrupts the Intestinal Barrier Integrity in Crohn's Disease by Interacting with OTUD4 and Activating the MYD88/NF-κB Pathway.

Elevated SPARC Disrupts the Intestinal Barrier Integrity in Crohn's Disease by Interacting with OTUD4 and Activating the MYD88/NF-κB Pathway.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 09, 2024

Identification of c-Met on Tumor Cells as a Novel Receptor for B7-H3 Entails Implications for Cancer Cell Stemness and Targeted Therapy.

Identification of c-Met on Tumor Cells as a Novel Receptor for B7-H3 Entails Implications for Cancer Cell Stemness and Targeted Therapy.

Journal: MedComm
Published: April 17, 2024

RBP7 functions as a tumor suppressor in HR + breast cancer by inhibiting the AKT/SREBP1 pathway and reducing fatty acid.

RBP7 functions as a tumor suppressor in HR + breast cancer by inhibiting the AKT/SREBP1 pathway and reducing fatty acid.

Journal: Cancer cell international
Published: October 25, 2023

High expression of B7-H3 on monocyte/macrophages in tumor microenvironment promotes lung cancer progression by inhibiting apoptosis.

High expression of B7-H3 on monocyte/macrophages in tumor microenvironment promotes lung cancer progression by inhibiting apoptosis.

Journal: Translational oncology
Published: October 16, 2023

Pharmacological suppression of HHLA2 glycosylation restores anti-tumor immunity in colorectal cancer.

Pharmacological suppression of HHLA2 glycosylation restores anti-tumor immunity in colorectal cancer.

Journal: Cancer letters
Published: August 25, 2023
Showing 1-12 of 85

Last Updated: 09/26/2026